Call Options

26 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $41.9 Million - $51 Million
-256,000 Reduced 66.0%
131,900 $26 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $665,597 - $777,268
-4,300 Reduced 1.1%
387,900 $66.5 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $48.9 Million - $55.7 Million
305,700 Added 353.41%
392,200 $71.4 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $32.5 Million - $36.6 Million
-235,900 Reduced 73.17%
86,500 $13.4 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $2.26 Million - $2.61 Million
16,900 Added 5.53%
322,400 $48.1 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $35.9 Million - $44.7 Million
271,300 Added 793.27%
305,500 $41.2 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $12.5 Million - $14.4 Million
-86,700 Reduced 71.71%
34,200 $5.45 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $30 Million - $36 Million
-216,900 Reduced 64.21%
120,900 $19.6 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $1.57 Million - $1.8 Million
11,700 Added 3.59%
337,800 $45.3 Billion
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $24.6 Million - $31.3 Million
178,800 Added 121.38%
326,100 $49.9 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $6.44 Million - $7.99 Million
-48,800 Reduced 24.89%
147,300 $23.9 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $5.35 Million - $5.89 Million
-52,272 Reduced 21.05%
196,100 $21.2 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $9.04 Million - $12.2 Million
-112,364 Reduced 31.15%
248,372 $26.6 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $1.59 Million - $1.87 Million
-18,532 Reduced 4.89%
360,736 $31.6 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $14.8 Million - $19.8 Million
201,268 Added 113.07%
379,268 $37.2 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $3 Million - $4.55 Million
46,500 Added 35.36%
178,000 $13.6 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $7.98 Million - $9.99 Million
110,700 Added 532.21%
131,500 $11.6 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $6.59 Million - $7.93 Million
-104,700 Reduced 83.43%
20,800 $1.58 Million
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $1.54 Million - $1.97 Million
23,500 Added 23.04%
125,500 $9.13 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $15.1 Million - $17.8 Million
-195,600 Reduced 65.73%
102,000 $8.22 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $3.01 Million - $3.72 Million
-38,700 Reduced 11.51%
297,600 $27.4 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $32.6 Million - $36.2 Million
-366,500 Reduced 52.15%
336,300 $31.8 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $31.9 Million - $37.8 Million
-355,700 Reduced 33.6%
702,800 $65.1 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $20.9 Million - $28 Million
-227,400 Reduced 17.68%
1,058,500 $100 Million
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $70.2 Million - $76.9 Million
783,300 Added 155.85%
1,285,900 $124 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $35.1 Million - $44.8 Million
502,600
502,600 $44.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.